Диссертация (1174184), страница 5
Текст из файла (страница 5)
.. ., β016; Khazaie Y. et al., 2014].,-,,.147γ0()(-)ё-,(),-,,Fas-.-(n=30)(-)-,,29.29(M±Ц),,%/19,γ±β,038,83,4ββ,4±1,638,63,2,%,%( nV+/PI–)-( >0,05) (β526). Fas.(83%)γ0(FКs+)(-)5%.,-,,148-(Fas+)() ( >0,05).-966)((23%,25).-.-,-( >0,05),1(,26).β0% ( 6γ0)β0-,(AnV+/PI–)40( nV+/PI–)-.( nV+/PI–)--β0-30.ё()-()(№ β6β054β. 04.05.β016 .)..14930,(%))(-β0(-)( nV+/PI–)-(Mm),(AnV+/PI–)-(n=28).
(%)(n=32)(n=30),%5-1011-1516-20β122 (79)6 (21)––24 (86)4 (14)––11 (37)19 (63)––9 (29)15 (51)2 (7)4 (13)4 (12)6 (19)18 (56)4 (13)3 (11)7 (21)17 (53)5 (15):-,=7,1P=0,1–2f=4β,194β0,.--,.1/AnV-FITCPI,,AnV-FITC.1,1-(31).150pH=7,4,,AnV-FITC«PI».31-1.2,72.0,83.1,14.2,05.1,76.0,57.0,68.1,09.0,710.0,711.2,012.1,713.0,914.0,615.0,716.1,017.1,118.1,519.0,820.0,721.1,022.0,723.0,924.0,825.1,026.1,027.0,828.0,929.0,930.1,0//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////10,9–20,9–31,0–40,8–1515678910111213141516171819202122232425262728––––––––––––––––––––––––0,710,70,80,91,10,70,70,90,90,90,90,61,00,60,80,70,70,90,60,80,60,71,0,1,1,-1,1.6γ0β0,.3.3.2.,,Fas-152-/.,.ё(3832).32,, ё,(V+)(Mm; n=38),%())γ8,γ±β,5γ8,6±1,6*6,6±0,5*12,0±1,4*4β,8±1,γ**61,82,268,8±1,810,1±0,45,9±0,715,2±1,5AnV–/PI–AnV+/PI–AnV+/PI+AnV–/PI+(0,65±0,0361,4±2,6* ˂0,001,1,6-., .
.:(%)(%)=100 %(%)15361,4±β,6%,. .-50%.,( ˂0,001)PI().ёё(AnV–,/PI–)-1,8,(AnV+/PI–)1,5.ёё,-PIёβ,8(AnV–/PI+)-,β(AnV+/PI+)(()((AnV+/PI–)((AnV+/PI–)=32)./)):0,65±0,0γ.,,ё,(V+),(33):,ё-,(V+);---(AnV–/PI–)154(r=0,56; <0,001);( ЧV+/PI+)(r= –0,5β; <0,001).33-(r),ё,(-V+),%,%*<0,001()(r0,290,01–0,30–0,12AnV–/PI–AnV+/PI–AnV+/PI+AnV–/PI+)r0,56*0,08–0,52*–0,17,,FКs-,( >0,05).Chlamydia3.3.3.trachomatis,Chlamydia trachomatisё–.155--Chlamydia trachomatisё-.Chlamydia trachomatis. .[., 1982; АОsЭpСКХ-. et al., 1965; Galanos C.
et al., 1969; Nurminen M. et-al., 1985],,-,().Chlamydia trachomatisNurminen M.. [Hosseinzadeh S.,Hosseinzadeh S.,2003],:,-ё-,,(,),,-,,,-,,;,-,-ё,156,Chlamydia trachomatis,,.,-,ё,,--.,-,Д. .., 1983;. ., β006],[Gorga F. et al., 2001].Chlamydia trachomatisHosseinzadeh S. [Hosseinzadeh S.,-Chlamydia trachomatis2003].-(№ 259394613.04.2015 .),-, .
..Chlamydia trachomatis,-- -.. .[Chlamydia trachomatis., 1981]--[Nurminen M. et al., 1985],.Hosseinzadeh S.[Hosseinzadeh S. et al., 2003].Chlamydia trachomatis,Hosseinzadeh S. [Hosseinzadeh S. et,al., 2003]157-ё-,-,- .,Chlamydia,trachomatisё.Chlamydia trachomatis50Chlamydia trachomatis (β,590%-),-550°C.ё155000(γ0-/,7,5)0,1-HCХ-Chlamydia trachomatis-1:9.4- ).(Pharmacia,,- (-HCХ7,5),-ё.-1,0,4–0,45D-=8,0.-HCХN-,-,)Д(., 1982],.-HCХ.
.,–β0°C.Chlamydia trachomatis14%-,158-E.coli (055:B5, «Sigma»).(8).1 –,Chlamydia trachomatis (;E.coli (055:B5, Sigma).)2 –8.,-Chlamydia trachomatis.-Chlamydia trachomatis,(mydiaChla-1)trachomatis,HosseinzadehS. (2)[Hosseinzadeh S. et al., 2003].,,,0,9%-,-NКCХ.:-,–. . 1958;[,. .., 1982; Lowry O. et al., 1951; Dubois M., 1956].,(1)Hosseinzadeh S. (1592),-(β–γ%),-:(6,2%)2(3,5%), . .(34).34-Chlamydia trachomatis,((1)Hosseinzadeh S.2),%,%11,042,00326,240,33,52,4Chlamydia trachomatis,,,-.:Chlamydia tracho-matis,(-Chlamydia trachomatis,0);(Chlamydia tra-1);Hosseinzadeh S.
(chomatis,2).0,(12,9),.Chlamydia,trachomatis,0;,1,15,4; 17,8; βγ,γγ–42γ1.1601-.-0120,9.0–chomatis,C. trachomatis,C.trachomatis,;1–;2 –Hosseinzadeh S.16112C. tra-ёChlamydia trachomatis08%;1– 94,7%;2– 77,6%.,Chlamydia tracho-matis ()25.6(64,5±β,7%/PI–)-).,(AnV+/PI–)-ё(AnV–(AnV+/PI+)-/PI+)-(AnV–35.35, ё,(-V+)(Mm;n=25),%(6)68,0±β,19,γ±0,76,4±0,816,γ±1,1■AnV–/PI–AnV+/PI–AnV+/PI+AnV–/PI+- (1-, 56° )1β,5±1,5*1β,γ±1,59,0±1,466,β±1,7*1,3±0,2<0,001; *;;oβ(STS, 1/ )ββ,4±β,5*46,7±β,9*1β,0±1,1*18,9±β,6#5,0±0,3(γC.
trachomatis,0,1/ )44,5±β,8*β7,5±β,4*, o8,5±1,γ19,5±1,γ#γ,0±0,γ-#STS,1 ) (ё,(56°1)(AnV–/PI+)-(66,β±1,7%).-( >0,05)(AnV+/PI–)-1β,γ±1,5%162.1(STS)/6β)(-546,7±β,9%(AnV+/PI–)-( ˂0,001), . ..ё,, . .(AnV+/PI+)-(1β,0±1,1%)( ˂0,001).,-(AnV–/PI+)--( ˂0,001),-18,9±γ,0%STS( >0,05),1).(6Chlamydia trachomatis ()-1,54γ,1±γ,0%( ˂0,001).,.«trachomatis»,6Chlamydiaγ)(.ё(AnV+/PI–).,γ(AnV+/PI–)( ˂0,001).STS (β),(β7,5±β,4%(AnV+/PI–)46,7±β,9%,) ( ˂0,001).ё(AnV+/PI+)--19,5±1,γ% (AnV–/PI+)-8,5±1,5%,( >0,05).163ёChlamydia tracho-(AnV–/PI+),matis1)(( ˂0,001).(AnV+/PI–)Chlamydia trachomatis(AnV+/PI–)-STS(A=A o o/A o oo):o:35Chlamyd-ia trachomatis (γ,0±0,3)STS (5,0±0,γ).-(AnV+/PI–),.6Chlamydia trachomatis ()-(r= –0,9; <0,001)-(AnV+/PI–) --.(Fas+)-STS( >0,05).Chlamydia trachomatis3.3.4.«»–22,,,40)2022)460,01,9%164-(20-2.(H2,-βγ,1±1,4%( ё)-.(AnV+/PI–)( >0,05)(-36).36-(AnV+/PI–)22(Mm)(AЧV+/PI–)-(n=20)4β()1β5ββ002(n=20)4β10,7±1,β9,β±0,516,7±1,717,5±1,β9,6±1,β11,3±1,719,7±β,6β1,4±β,654,8±4,1*β4,9±γ,γ*, #β7,9±5,3β4,1±γ,722,%2˂0,001; *(22);#2-5β00H22.22.β22(β00β),,,AnV, .
. (AnV+/PI–) -50%,( ˂0,001) (5,,10).PI (,ё),γ0% (γβ,4±γ,0%).1β,8±β,γ%(AnV–/PI–)-.β004H2ё271,0±γ,γ%βAnVβ-( ˂0,001).165,β00(AnV+/PI–)-4-,.H22β,7А(a)V-FITC;( )-; (c).10 μЦV-FITC10.in vitro β00(H2ё2)–,PI.PIβ00.,22,,PI,,,( <0,01): 71,0±γ,γ%,362551,6 ± 5,4%β- ,22(-.41)-(AnV+/PI–)--( >0,05).(AnV+/PI–)-β001662):((AnV+/PI–)-2/A o oA=A o o ooo .β0025,0±0,8,22-412,8±0,γ.,,2--in vitr2.(AnV+/PI–)-( >0,05),,( ˂0,001) ((25(200)22)(,36).22(-1),(AЧV+/PI–)-2),( >0,05).,FКs-,( >0,05).-3.3.5.–,,40β0(20167)-ё-, . .,Fas--.γ7°-2(4-)( >0,05),4-( ˂0,05) (1,5-37).37(AnV+/PI–)(Mm),(n=20))10%(AnV+/PI–10,5±0,542,13,0**AnV+/PI–AnV+/PI–16,8±1,410,9±1,β10,γ±0,718,γ±1,536,82,7**65,72,39,7±1,1***234,53,0**17,6±1,4**27,33,2**410,7±1,ββ4,γ±γ,665,52,37,6±1,0**9,β±0,5β7,6±5,β60,01,94,8±0,9*** ˂0,05, ** ˂0,00110(60/(16,4±1,4β1,8±β,7**12,9±1,215,5±1,γAnV+/PI–10,1±0,461,82,21(n=20))10(116,6±1,γβ4,β±β,6216,7±1,7β0,6±β,γ417,5±1,β14,1±β,0#10); # ˂0,05.)-1,5β( ˂0,001).1681()1,8,-β,5( ˂0,001).(4-)β,β,-3( ˂0,001).(AnV+/PI-)(-β)4,( >0,05).,( ˂0,001) (60/(37).)(AnV+/PI–)10,( >0,05).1-β1,5(AnV+/PI–)--( ˂0,05),-4-(AnV+/PI–)( ˂0,001).260(AnV+/PI–)(AnV+/PI–)-(=//):.41,9±0,1,-,in vitr.169-,37,60/()-(AnV+/PI–)( >0,05).,(FКs+)( >0,05).3.3.6.«»–-FasL-,,(CD95)Fas-.FasL-.,: 14β8,14Fas–-.3814-/FasL ()-(AnV+/PI–)( >0,05).38-(AnV+/PI–)FasL (M (25;75))(AnV+/PI–)( FasL)9,5 (9,0; 11,8)(n=14)9,55 (7,5; 10,0)( FasL)19,5 (15,3; 25,0)170,%(n=14)19,0 (15,8; 22,5)in vitro3.4.2-2α,2,-2-α-in vitro-,ё–.β002-22,(Sigma).6030: 30-.in vitroγ002600((1)β)(AnV+/PI–))(( >0,05) (39).(4-γ00)600,(AnV+/PI–)β( >0,05).,γ00(4),β-600(β001715)222,:4-2-(AЧV+/PI–),545,7γ2-2( ˂0,0β),1(AnV+/PI–)22(β>0,05).39(AnV+/PI–)(M (in vitro25;275))(AЧV+/PI–)-,%(n=10)(( γ00( 600( β00( γ00( 600(<0,02; *β00)1)2)34+ β005+ β002)2(n=10)9,1 (8,0; 9,9)19,5 (15,3; 24,0)10,5 (7,0; 13,0)23,0 (16; 32,8)7,5 (6,3; 10,8)20,0 (16,0; 24,5)48,5 (34,0; 65,5)*19,0 (9,8; 43,3)#222)2)11,0 (8,3; 12,8)20,5 (15,0; 29,5)#20,0 (14,3; 23,5)8,5 (7,3; 12,3);2#γ2)(β-4),(β005)22(AnV+/PI–)(γ) ( >0,05) (39).172α-in vitro402α-60((1)β)(AnV+/PI–))(( >0,05) (4-40),β-( >0,05).40(AnV+/PI–)in vitro α-(M (β25;75))(AЧV+/PI–)-,%(n=10)(( 60( β00( 40α-( 60(α-<0,02; *8,5 (7,2; 9,8)17,0 (14,5; 24,3)10,5 (6,3; 12,8)19,0 (14,3; 22,3)9,4 (7,5; 10,0)17,0 (11,3; 21,5)55,5 (48,3; 67)*21,5 (7,8; 46,0))1α2α3( 40))24+ β005+ β002)222)2)#21,0 (16,3; 23,8)#19,5 (14,3; 23,5)13,0 (9,8; 18,8)12,5 (9,3; 14,8);β00(n=10)#γ2)2,40α-(4),60β-β002:5(,(AЧV+/PI–)41735)22-2-4γ2-2( ˂0,0β),(AЧV+/PI–)α-22(1β>0,05).(α-4),(β-5)β0022-(AnV+/PI–)-( >0,05) (40).+ α-in vitroβ-(n=10)– γ0040α-(+1)((AЧV+/PI–)--) ( ˂0,0β),-– 600(AЧV+/PI–)-+ 60α-( ˂0,0β) ((β)11).-4β-(AnV+/PI–)( >0,05).ββ0022(,45)ё2:(AnV+/PI–)--4174,8,7%,2-5γ13,5%22( ˂0,0β).(AnV+/PI–)-11.(in vitro1 – γ003 – β0025 – 600+ 60<0,0β; *2;+ 40α4 – γ00α+ β00γ(;+ 402 2.(β002 – 600α-+ β00+ α-+ 60α2);2);2;#-2).(n=10)2--– 300+ 40α-– 600+ 60α-((1),-β)(AnV+/PI–))(( >0,05) (4-12),(AnV+/PI–)β-( >0,05).175(AnV+/PI–)-12.-in vitro(+ α-1 – γ003 – β0025 – 600+ 60* <0,0β2;)+ 40α4 – γ00α+ β00;2+ 402.(2 – 600α-+ β00+ 60α2;2;)β-β0022(45)γ(AnV+/PI–)22( >0,05).(2-2)(AЧV+/PI–)( ˂0,0β).176-3.5.,,-.( nV+/PI–).,,:1); 0,1/ STS (6/-); β0022(β-)Chlamydia trachomatis (660/).(4-,(AnV+/PI–)( >0,05) (41).41(r),(AnV+/PI–)STS■■■STS22C.
trachomatisβ00(β(n=20)2–0,3■■-2C. trachomatis)(4–0,30,150,040,190,07■)–3.6.–––.177-,-.ё. ., β01β, 2013;[. ., β01γ , 2014 ].––(-),.––,ё-,,..3.6.1.3.6.1.1.ё-()Д. .., 2002],. .,β.ёёFas-)(.75178-4134-,((Fas+) -13).13.14.15,,(AЧV+/PI–)-(FКs+)--(42).,,( ˂0,001):β,,.–(.179-/)46,7,14.15.18042ё(Mm),%(n=34)(n=41)* ˂0,001( nV+/PI–)(Fas+)10,0±0,4γ,9±0,417,8±1,5*1β,4±1,1*,//242,0±22,4 184,0±21,8 1,1 – 2,6127,3±10,7*4,4 – 10,327,6±3,0*,( nV+/PI–)--(r=0,5; <0,01).3.6.1.2. Иin vitro,–-,.-in vitro.«»,38.,β4-1–4.181100-:β4-10-310-6, 10-5,.(AnV+/PI–)( <0,001),10-310-5,.,/10-54,6,7,/ –81410010-3.,(10-6/ ) Д. .,-2011],,,β%.,43,(AnV+/PI–)(AnV+/PI–)-(=):/4324(, Mm),-6p<0,001; *,/101010-30,56 ± 0,01*1,7β ± 0,04*γ,55 ± 0,0γ*0,61 ± 0,01*, #1,15 ± 0,01*, #β,10 ± 0,01*, #;-5#1,1–.182,43β4-:,.–3.6.2.–-,3.6.2.1.. .,.Д-.
., 1990],,,-,-:ё-,,,..-:1.;β.;γ.;;4.5..ИИИ(0,440°80°)β0.-183., 1986],[(. .[) –., 1989]..45-44.44%,°404550556065707546547676%9876625443372417/1001001008987858364,%1,061,72,42,83,74,15,44,970° ,()5,-.И.ё..«».,(6000/, γ0),-HCl-SЭТrrОН UХЭrКПТХЭrКЭТШЧ CОХХspH 7,4Models 8010..184..-45.45,/62,461,2861,4454,1227,423,0000,51,01,51,752,02,5,/,/–005,8524,6053,052,18,-,/–65,0450,52150,02850,03245,03950,07135,07050,05900,504575,03700,01880,01550,010,991,20,30,991,871,52-,, . .β,0β,0.-,.И( I)-«».16I105,5.I=7,β,.γ9.18551--16.И(--)«».-114,(1β917).,ё.46.ёё(),γβ,5±β,7 KD.,ё,6,,50%.186--17.G-2001,β 95,0,1,5.46ё ,,,-,,%3,021378,0192,9100180,41680,095,049,256,3Иё,Д.
.., 1990],.[Weeke-B., 1973],- ,187,(),(Ephydatia fluviatilis) (18).18.1-4 –:; 7–5, 10, 15, β0/; 8–; 5, 6, 7, 8, 9, 10 –: 5–; 6–; 9–- ; 10–47%.,. ..,1981;.[., β00γ;. ..,2013],((- ).-)..(Ephydatia fluviatilis),Д188. .-., 2013].ёД. .., 1990].47*–100495,5±1,0671,0±γ,5α-L-654,0±6,5-D-535,0±β,0D-720,0±1,β1015,0±β,0,,,-D)ДDD*%6α-Dα-Dα-Dα-D--,(. ., β01γЖ.. ., 1981;.., 2003;-И,,№ β5β4668(.06.05.β01γ .).-,:1)1700γ0.,518917% (44).-ё-,, . ..-2)(50%).3)(EpСвНКЭТК ПХЮЯТКЭТХТs).(98,5%)(47)..48ё.,,-,-100% ().48,/,,/59,047200,00,006283,222,016720,00,025418,04,755370,00,068367,51,821,79,76211,75,(%)1001147,6(100)129,8(87,9)74,8(50,7)4,211,31626,7Д. .., 1990],(γ190)γ,5-(β0-)., . .γ0%. .,-(Ephydatia fluviatilis).(3,24 10-4-)Д. .144., 2013].(–)(-48).(Ephydatia fluviatilis).19,. .Д,.